brequinar has been researched along with Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horvat, NK; Lesinski, GB | 1 |
| Abrams, SI; Amitrano, AM; Barbi, J; Colligan, SH; Kramer, ED; Morreale, B; Nemeth, MJ; Opyrchal, M; Peresie, J; Singh, PK; Sykes, DB; Wang, J; Yu, H; Zollo, RA | 1 |
| Azarnia, N; Cody, R; Dallaire, B; DeForni, M; Gyves, J; Moore, M; Stewart, D | 1 |
| Cleaveland, ES; Cooney, DA; Ford, H; Kelley, JA; Paull, K; Zaharevitz, DW | 1 |
1 trial(s) available for brequinar and Breast Cancer
| Article | Year |
|---|---|
Multicenter phase II study of brequinar sodium in patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biphenyl Compounds; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis | 1993 |
3 other study(ies) available for brequinar and Breast Cancer
| Article | Year |
|---|---|
Bring on the brequinar: an approach to enforce the differentiation of myeloid-derived suppressor cells.
Topics: Biphenyl Compounds; Breast Neoplasms; Cell Differentiation; Female; Humans; Myeloid-Derived Suppressor Cells | 2022 |
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression.
Topics: Animals; Breast Neoplasms; Female; Humans; Immunologic Factors; Immunotherapy; Mammary Neoplasms, Animal; Mice; Myeloid-Derived Suppressor Cells; Programmed Cell Death 1 Receptor | 2022 |
Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar.
Topics: Antineoplastic Agents; Aspartic Acid; Biphenyl Compounds; Breast Neoplasms; Carbolines; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Colonic Neoplasms; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Female; Humans; Kidney Neoplasms; Kinetics; Leukemia; Lung Neoplasms; Male; Melanoma; Mitochondria; Orotic Acid; Ovarian Neoplasms; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Prostatic Neoplasms; Ribonucleotides; Sodium Bicarbonate; Software; Tumor Cells, Cultured | 1996 |